Desmopressin vs Tesamorelin
Overview
Desmopressin is primarily a hormonal peptide, while Tesamorelin is used for performance & growth.
This page compares Desmopressin and Tesamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | Tesamorelin | |
|---|---|---|
| Category | Hormonal | Performance & Growth |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | 2 mg |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | daily |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Visceral fat reduction, improved body composition, GH release |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Joint pain, peripheral edema |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while Tesamorelin falls under Performance & Growth. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Desmopressin: FDA-approved. Tesamorelin: FDA-approved.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). Tesamorelin is typically dosed at 2 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and Tesamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and Tesamorelin?
- Desmopressin is primarily a hormonal peptide, while Tesamorelin is used for performance & growth. Desmopressin is FDA-approved for one or more indications, whereas Tesamorelin is FDA-approved for one or more indications.
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is Tesamorelin used for?
- GHRH for visceral fat.
- Can you take Desmopressin and Tesamorelin together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and Tesamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or Tesamorelin FDA-approved?
- Desmopressin is FDA-approved for one or more indications. Tesamorelin is FDA-approved for one or more indications.
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- Tesamorelin — full monograph: mechanism, research, dosing & references